Own capital
We invest family capital. Decisions are direct, alignment is clear and timing is not dictated by a fund cycle.
Private investment office · Zug, Switzerland
Permanent capital.
Operator judgment.
PG Equity Group invests family capital in commercial businesses where operating experience, strategic clarity and long-term ownership can materially influence the outcome.
We invest as principals.
We do not manage third-party capital, provide investment advice or solicit public investment.
Approach
Built by operators,
not allocators.
We concentrate capital where execution matters. Our work begins with a clear investment thesis and extends to the operating agenda, governance, financing and strategic exit.
Operating involvement
We engage where governance, commercial acceleration, M&A or capital structure can create measurable value.
Selective partnership
We work with high-conviction management teams, sponsors and co-investors when roles and objectives are explicit.
Investment focus
Concentrated where
experience compounds.
Artificial intelligence is an operating capability across the portfolio, not a separate theme.
Life Sciences & MedTech
Specialty pharma, medical devices and diagnostics where regulatory strategy, commercial execution and disciplined M&A can materially change the trajectory.
Critical Materials & Industrials
Strategic minerals, supply-chain assets and cash-generative industrial businesses with durable relevance to Western markets.
Select Special Situations
Carve-outs, buy-and-build platforms and structured growth opportunities where complexity creates an advantage for an experienced principal.
Selected engagements
Capital with an
operating mandate.
A selected view of current direct investments, operating platforms, board engagements and family philanthropy. Roles differ by organization and are stated explicitly.
Anchor Investor · Board Director · Audit Committee Chair
restor3d
Personalized orthopaedic solutions combining 3D printing, biomaterials, biomechanics and AI. Preparing for a potential IPO.
Anchor Investor · Board Director · Audit Committee Chair
Pressio Spine
Commercial-stage MedTech developing Nitinol-based fixation platforms for outpatient spine surgery.
Investor · Board Director
Huxley Medical
AI-enabled, FDA-cleared home sleep diagnostics designed to simplify and expand patient access.
Strategic Investor · Board of Advisors
Avicanna
A biopharmaceutical platform focused on cannabinoid-based products, clinical capabilities and international commercialization.
Founder · Executive Chairman
AltaNova Pharma
A Swiss specialty-pharma platform focused on chronic disease states and regulated access to clinically differentiated therapies.
Investor · Board Director · Audit Committee Chair
Freedom Metals
A Nasdaq-listed acquisition company focused on mining and critical-minerals businesses.
Anchor Investor
Dual Worlds
A blockchain venture applying distributed-ledger technology to financial services.
Founder · Chairman
Pasos de Esperanza / Steps of Hope Foundation
A family foundation funding surgeries, prosthetics, therapies and daily support for children with physical disabilities in Colombia.
Leadership
A record built inside operating companies.
25+years operating and investing
25+M&A Life Sciences transactions
Top 10global respiratory pharmaceutical company created from concept
$1.5B+profits distributed across multiple monetizations
55+countries in the Covis commercial footprint
Michael W. Porter
Co-Founder & Managing Partner
Michael is an investor and operator with more than 25 years of experience across Life Sciences, private equity, restructuring, M&A and capital markets.
As co-founder and CEO of Covis Pharma, he created the company from concept and built it into one of the world's 10 largest respiratory pharmaceutical companies, with more than $600 million in annual sales. Across multiple monetizations, the business distributed more than $1.5 billion in profits to shareholders, including 10x and 4x cash-on-cash outcomes. Michael has led more than 25 M&A Life Sciences transactions and expanded the Covis commercial footprint to more than 55 countries.
He now invests family capital and serves in board and executive-chair roles across MedTech, specialty Life Sciences and critical minerals. He speaks English, Spanish, Portuguese, Russian and German.
View public profile
Liliana Gomez
Co-Founder & Managing Partner
Liliana is Co-Founder and Managing Partner of PG Equity Group, which she established with Michael in 2015. She helps lead the family office's cross-border investment activity and strategic relationships across Europe and the Americas.
She brings more than 20 years of sales, marketing and operating experience in South Florida luxury real estate. Her work has spanned luxury residential development, distressed-asset portfolios and international sales operations, including directing more than $100 million of annual international sales at ISG World.
The Real Deal recognized Liliana among South Florida real estate's rising executives. Her market perspective has been featured by CNN, the Miami Herald and leading business publications across the United States and Latin America.
Liliana is also Co-Founder and CEO of Steps of Hope Foundation (Fundación Pasos de Esperanza), a US 501(c)(3) supporting vulnerable children in Colombia through prosthetics, surgeries, therapies and long-term care. She speaks English, Spanish and Portuguese and is currently learning German.
View public profileHistorical figures relate to prior operating and investment activity at Covis Pharma and are not presented as performance of PG Equity Group.
Contact
Relevant situations,
directly shared.
We welcome selective dialogue with founders, management teams, sponsors, family offices and advisers where our capital and operating experience are relevant.
Contact Michael PorterPG Equity GroupZug, Switzerland